Literature DB >> 3044554

Imipenem: a new carbapenem. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3044554      PMCID： PMC1268201     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  Imipenem: first of a new class of beta-lactam antibiotics.

Authors:  M Barza
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

2.  A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.

Authors:  G B Calandra; M Hesney; C Grad
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

3.  Comparative study of imipenem in severe infections.

Authors:  J D Baumgartner; M P Glauser
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

Review 4.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

5.  Imipenem versus moxalactam in the treatment of serious infections.

Authors:  L J Eron; D L Hixon; C H Park; R I Goldenberg; D M Poretz
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

Review 6.  Antibacterial activity of imipenem: the first thienamycin antibiotic.

Authors:  H Kropp; L Gerckens; J G Sundelof; F M Kahan
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.